GlassScriptPhysician profile
Amy M Otten
NPI 1568710689
$1,532.09
in general payments reported to CMS, 2019-2025
16 companies · $47.66 in 2025
The $47.66 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $34.24 · 2023: $1,329 · 2024: $121 · 2025: $47.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.86 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $317.30 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $241.66 | 2022-2024 | Verquvo, Lagevrio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $155.08 | 2022-2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $136.13 | 2023-2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $122.85 | 2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $101.75 | 2023 | Eliquis, Camzyos |
| Boston Scientific Corporation | $86.83 | 2023-2025 | Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $86.06 | 2023 | Repatha |
| Actelion Pharmaceuticals US, INC. | $83.36 | 2023 | Opsumit, Uptravi |
| Pfizer INC. | $81.68 | 2023-2024 | |
| Scpharmaceuticals INC. | $37.89 | 2023 | |
| Abiomed | $17.13 | 2023 | Impella |
| Kiniksa Pharmaceuticals, LTD. | $16.63 | 2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $16.44 | 2023 | Evkeeza |
| Sanofi-Aventis U.S. LLC | $16.10 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $15.20 | 2023 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Otten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.